Latest stories on APMD
Apnimed scouts $160m IPO to back late-stage sleep apnoea pill development
Yahoo Top58 · neutralgeneral
Sleep apnea pill developer Apnimed targets $608 million valuation in US IPO
Reuters58 · neutralgeneral
Shionogi-Backed Apnimed Seeks to Raise $160 Million in US IPO
Bloomberg28 · bearishgeneral
Apnimed Seeks IPO For OSA Treatment Commercialization
Seeking Alpha56 · neutralgeneral